About the CPD course
This course is aimed at GPs; nurse prescribers; PCN and practice pharmacists and pharmacy technicians; medicines optimisation teams and community pharmacists. The course is comprised of nine modules covering the lifestyle and pharmacological management of type 2 diabetes in adults; including the management of hypertension and lipids; in addition to blood glucose control. The course considers the 2022 update to NICE Guideline 28; particularly the implications of the cardiovascular outcome trials of the SGLT-2 inhibitors on the management of patients with established cardiovascular disease or cardiovascular risk factors.
Send an enquiry
PrescQIPP
We are an NHS funded not-for-profit organisation that supports quality, optimised prescribing for patients. We produce evidence-based resources and tools for primary care commissioners, and provide a platform to share innovation across the NHS. Most of our materials are publicly available, however we also provide a range of data and intelligence tools, webinars and events for our subscribers. We also aim to engage with a broad range of stakeholders including patients and carer groups, the pharmaceutical industry and voluntary sector organisations.
Want to learn more?
More CPD courses by PrescQIPP
Business
Optimising medicines for adults with type 2 diabet...
PrescQIPP
The aim of this training package is to update practitioners on the content of the guidelines and to...
Online Course
Business
Medicines use in care homes: course 1
PrescQIPP
This is the first of several bespoke e-learning packages to support care home staff involved in any...
Online Course
Business
Care Homes 2 e-learning course
PrescQIPP
This is the second e-learning package to support care home staff involved in any aspect of medicines...
Online Course
Business
Anticoagulation; stroke prevention in Atrial Fibri...
PrescQIPP
This course is aimed at GPs; nurse prescribers; PCN and practice pharmacists and pharmacy technician...
Online Course
Get industry-related content straight to your inbox
Thank you for subscribing
By signing up to our site you are agreeing to our privacy policy